These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29247050)

  • 21. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
    Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.
    Weiss RG; O'Connell KM; Flucher BE; Allen PD; Grabner M; Dirksen RT
    Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1094-102. PubMed ID: 15201141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice.
    Aleman M; Zhang R; Feng W; Qi L; Lopez JR; Crowe C; Dong Y; Cherednichenko G; Pessah IN
    Mol Pharmacol; 2020 Oct; 98(4):351-363. PubMed ID: 32764093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal calcium signalling and the caffeine-halothane contracture test.
    Figueroa L; Kraeva N; Manno C; Toro S; Ríos E; Riazi S
    Br J Anaesth; 2019 Jan; 122(1):32-41. PubMed ID: 30579404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
    Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
    Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
    Dirksen RT; Avila G
    Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative malignant hyperthermia mutation Ca
    Feng W; Lopez JR; Antrobus S; Zheng J; Uryash A; Dong Y; Beqollari D; Bannister RA; Hopkins PM; Beam KG; Allen PD; Pessah IN
    J Biol Chem; 2023 Aug; 299(8):104992. PubMed ID: 37392848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
    Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
    Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
    Censier K; Urwyler A; Zorzato F; Treves S
    J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
    Foster PS; Denborough MA
    Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Halothane induces calcium release from human skinned masseter muscle fibers.
    Reyford H; Adnet PJ; Tavernier B; Beague S; Ferri J; Krivosic-Horber RM; Haudecoeur G
    Anesthesiology; 1999 Apr; 90(4):1019-25. PubMed ID: 10201673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia.
    Owen VJ; Taske NL; Lamb GD
    Am J Physiol; 1997 Jan; 272(1 Pt 1):C203-11. PubMed ID: 9038826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired interaction between skeletal ryanodine receptors in malignant hyperthermia.
    Liang X; Chen K; Fruen B; Hu J; Ma J; Hu X; Parness J
    Integr Biol (Camb); 2009 Sep; 1(8-9):533-9. PubMed ID: 20023768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.
    Lefebvre R; Legrand C; González-Rodríguez E; Groom L; Dirksen RT; Jacquemond V
    J Physiol; 2011 Nov; 589(Pt 22):5361-82. PubMed ID: 21969454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rem uncouples excitation-contraction coupling in adult skeletal muscle fibers.
    Beqollari D; Romberg CF; Filipova D; Meza U; Papadopoulos S; Bannister RA
    J Gen Physiol; 2015 Jul; 146(1):97-108. PubMed ID: 26078055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
    Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
    Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.